Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP266797.RAc5ZN4oBQfSaptJPHRaB4jNw9uPR_mlq5rHaMM1Qz1ak130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP266797.RAc5ZN4oBQfSaptJPHRaB4jNw9uPR_mlq5rHaMM1Qz1ak130_assertion type Assertion NP266797.RAc5ZN4oBQfSaptJPHRaB4jNw9uPR_mlq5rHaMM1Qz1ak130_head.
- NP266797.RAc5ZN4oBQfSaptJPHRaB4jNw9uPR_mlq5rHaMM1Qz1ak130_assertion description "[The results of the current study suggest that a lack of expression of CD44, especially CD44v6, is correlated with lymph node metastases and poor prognosis, and may be a prognostic factor for patients with EHBD/ampullary carcinoma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP266797.RAc5ZN4oBQfSaptJPHRaB4jNw9uPR_mlq5rHaMM1Qz1ak130_provenance.
- NP266797.RAc5ZN4oBQfSaptJPHRaB4jNw9uPR_mlq5rHaMM1Qz1ak130_assertion evidence source_evidence_literature NP266797.RAc5ZN4oBQfSaptJPHRaB4jNw9uPR_mlq5rHaMM1Qz1ak130_provenance.
- NP266797.RAc5ZN4oBQfSaptJPHRaB4jNw9uPR_mlq5rHaMM1Qz1ak130_assertion SIO_000772 10547541 NP266797.RAc5ZN4oBQfSaptJPHRaB4jNw9uPR_mlq5rHaMM1Qz1ak130_provenance.
- NP266797.RAc5ZN4oBQfSaptJPHRaB4jNw9uPR_mlq5rHaMM1Qz1ak130_assertion wasDerivedFrom befree-2016 NP266797.RAc5ZN4oBQfSaptJPHRaB4jNw9uPR_mlq5rHaMM1Qz1ak130_provenance.
- NP266797.RAc5ZN4oBQfSaptJPHRaB4jNw9uPR_mlq5rHaMM1Qz1ak130_assertion wasGeneratedBy ECO_0000203 NP266797.RAc5ZN4oBQfSaptJPHRaB4jNw9uPR_mlq5rHaMM1Qz1ak130_provenance.